Literature DB >> 30603890

Feasibility of simultaneous 99mTc-tetrofosmin and 123I-BMIPP dual-tracer imaging with cadmium-zinc-telluride detectors in patients undergoing primary coronary intervention for acute myocardial infarction.

Yoshihiro Yamada1, Shintaro Nakano2, Youdou Gatate1, Nanami Okano3, Toshihiro Muramatsu1, Shigeyuki Nishimura1, Ichiei Kuji4, Kenji Fukushima4, Ichiro Matsunari3.   

Abstract

BACKGROUND: Simultaneous dual-tracer imaging using isotopes with close photo-peaks may benefit from improved properties of cadmium-zinc-telluride (CZT)-based scanners.
METHODS: Thirty patients having undergone primary percutaneous coronary intervention for acute myocardial infarction underwent single-(99mTc-tetrofosmin (TF) or 123I-BMIPP first) followed by simultaneous 99mTc-TF /123I-BMIPP dual-tracer imaging using a Discovery NM/CT 670 CZT. The values for the quantitative gated-SPECT (QGS) and the quantitative perfusion SPECT (QPS) were assessed.
RESULTS: The intra-class correlation (ICC) coefficients between the single- and dual-tracer imaging were high in all the QGS and QPS data (Summed motion score: 0.95, summed thickening score: 0.94, ejection fraction: 0.98, SRS for 99mTc-TF: 0.97/ for 123I-BMIPP: 0.95). Wall motion, wall thickening and rest scores per coronary-territory-based regions were also comparable between the single- and dual imaging (ICC coefficient > 0.91). The interrater concordance in the visual analysis for the infarction and perfusion-metabolism mismatch was significant for the global and regional left ventricle (P < 0.001).
CONCLUSION: The quantitative/semi-quantitative values for global and regional left-ventricular function, perfusion, and fatty acid metabolism were closely comparable between the dual-tracer imaging and the single-tracer mode. These data suggests the feasibility of the novel CZT-based scanner for the simultaneous 99mTc-TF /123I-BMIPP dual-tracer acquisitions in clinical settings.

Entities:  

Keywords:  CZT camera; Perfusion-metabolism mismatch; acute myocardial infarction; dual imaging

Mesh:

Substances:

Year:  2019        PMID: 30603890     DOI: 10.1007/s12350-018-01585-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  40 in total

Review 1.  Myocardial 'stunning' in man.

Authors:  R Bolli
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

Review 2.  Imaging of myocardial fatty acid metabolism with PET.

Authors:  Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

3.  Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia.

Authors:  Vasken Dilsizian; Timothy M Bateman; Steven R Bergmann; Roger Des Prez; Martin Y Magram; Anne E Goodbody; John W Babich; James E Udelson
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

4.  Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy.

Authors:  P R Franken; P Dendale; F De Geeter; D Demoor; A Bossuyt; P Block
Journal:  J Nucl Med       Date:  1996-05       Impact factor: 10.057

5.  Prediction of functional outcome by quantification of sestamibi and BMIPP after acute myocardial infarction.

Authors:  A S Hambÿe; A Vervaet; A Dobbeleir; P Dendale; P Franken
Journal:  Eur J Nucl Med       Date:  2000-10

Review 6.  Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

Authors:  W C Stanley; G D Lopaschuk; J L Hall; J G McCormack
Journal:  Cardiovasc Res       Date:  1997-02       Impact factor: 10.787

7.  Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.

Authors:  N Tamaki; E Tadamura; M Kawamoto; Y Magata; Y Yonekura; Y Fujibayashi; R Nohara; S Sasayama; J Konishi
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

8.  Simultaneous acquisition of (99m)Tc- and (123)I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.

Authors:  Masato Kobayashi; Ichiro Matsunari; Kodai Nishi; Asuka Mizutani; Yoshiharu Miyazaki; Kazuhiro Ogai; Jyunko Sugama; Kazuhiro Shiba; Keiichi Kawai; Seigo Kinuya
Journal:  Ann Nucl Med       Date:  2016-01-08       Impact factor: 2.668

9.  Influence of methodology on the presence and extent of mismatching between 99mTc-MIBI and 123I-BMIPP in myocardial viability studies.

Authors:  A A Dobbeleir; A S Hambye; P R Franken
Journal:  J Nucl Med       Date:  1999-05       Impact factor: 10.057

Review 10.  New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease.

Authors:  Oyebola O Sogbein; Matthieu Pelletier-Galarneau; Thomas H Schindler; Lihui Wei; R Glenn Wells; Terrence D Ruddy
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

View more
  3 in total

1.  Experimental evaluation of the GE NM/CT 870 CZT clinical SPECT system equipped with WEHR and MEHRS collimator.

Authors:  Toshimune Ito; Yohji Matsusaka; Masahisa Onoguchi; Hajime Ichikawa; Koichi Okuda; Takayuki Shibutani; Masaaki Shishido; Kozo Sato
Journal:  J Appl Clin Med Phys       Date:  2021-01-10       Impact factor: 2.102

2.  Satisfied quantitative value can be acquired by short-time bone SPECT/CT using a whole-body cadmium-zinc-telluride gamma camera.

Authors:  Tomohiko Yamane; Masafumi Takahashi; Yohji Matsusaka; Kenji Fukushima; Akira Seto; Ichiei Kuji; Ichiro Matsunari
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

Review 3.  New Radionuclides and Technological Advances in SPECT and PET Scanners.

Authors:  Nicholas P van der Meulen; Klaus Strobel; Thiago Viana Miranda Lima
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.